ALBERT

All Library Books, journals and Electronic Records Telegrafenberg

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
Filter
  • Russell's viper venom protease  (1)
  • cyclic AMP derivatives  (1)
  • 1
    Digitale Medien
    Digitale Medien
    Springer
    The protein journal 2 (1983), S. 171-185 
    ISSN: 1573-4943
    Schlagwort(e): blood coagulation factor V ; snake venoms ; thrombocytin ; Russell's viper venom protease
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Chemie und Pharmazie
    Notizen: Abstract Thrombin activation of factor V constitutes an important feedback reaction in the regulation of coagulation. We therefore examined the details of activation of bovine factor V by two purified snake venom proteolytic enzymes, factor V-activating protease from Russell's viper venom and a platelet-aggregating enzyme, thrombocytin, fromBothrops atrox venom. The reactions were followed by changes in factor V coagulant activity, immunoelectrophoresis, and electrophoresis of radiolabeled factor V in sodium dodecylsulfate under reducing conditions. When factor V (M r 330,000) was exposed to factor V-activating protease at an enzyme-to-substrate ratio of 1:35 at 37°, cleavage occurred in 1 min, with formation of an intermediate (M r 250,000) coincident with a nine-fold activity increase. By 2 min, additional cleavage occurred, with disappearance of the intermediate and formation of two final fragments (M r 150,000 and 100,000) but no further change in coagulant activity. The concentration of these components remained unchanged from 5 to 15 min. Immunoelectrophoresis against antiserum directed against factor V confirmed cleavage of the molecule. Incubation of factor V with thrombocytin at 37° for 1 min resulted in a four-fold increase of factor V activity, with the formation of an intermediate (M r 220,000). By 2 min, a 7.5-fold activation was found, with a decline in the concentration of the intermediate; the predominant species hasM r =130,000. At 5 min the intermediate disappeared and a second, final fragment ofM r of ∼150,000 appeared without further change in coagulant activity. Immunoelectrophoresis again confirmed selective proteolysis. Thus, incubation of factor V-activating protease or thrombocytin with factor V results in different molecular alterations associated with an increase in the coagulant activity of this clotting factor.
    Materialart: Digitale Medien
    Standort Signatur Erwartet Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    ISSN: 1573-4943
    Schlagwort(e): cyclic AMP derivatives ; affinity labels ; chemical modification of enzymes ; nucleotide affinity labels ; cAMP phosphodiesterase
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Chemie und Pharmazie
    Notizen: Abstract The syntheses of two potential cAMP affinity lables, 1,N 6-(3-iodopropyleno)adenosine 3′,5′-cyclic-monophosphate and 2′-O-(2-iodo-3-hydroxypropyl) adenosine 3′,5′-cyclic-monophosphate, by a two-step chemical procedure are described. TheN 6- and 2′-O-allyl intermediates were prepared selectively by alkylation of cAMP in organic and alkaline aqueous solutions, respectively. Treatment of theN 6-allyl derivative withN-iodosuccinimide resulted in iodine addition to the double bond and cyclization to theN 1 position of the purine ring. The iodohydrin analog was synthesized by reaction of 2′-O-allyl-cAMP with potassium iodide and thallium trichloride in acetate buffered solution. The products were isolated by column chromatography and characterized by thin-layer chromatography, elemental analysis, and ultraviolet,13C, and1H NMR spectroscopy. The cAMP analogs were found to react with lysine and cysteine. Both cAMP derivatives were tested for their reaction with the low-K m cAMP phosphodiesterase of human platelets. The ribose-substituted analog functioned as a competitive inhibitor (K I =0.72 μM) and caused a time-dependent irreversible inactivation of the phosphodiesterase. In contrast, the purine-substituted derivative acted neither as a reversible competitive inhibitor nor as an irreversible inactivator of the enzyme. These results indicate the specificity of these potential cAMP analogs in their interaction with the phosphodiesterase.
    Materialart: Digitale Medien
    Standort Signatur Erwartet Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...